Non-propagative hPIV2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2. Ohtsuka et al.
Published: 27 October 2021| Version 1 | DOI: 10.17632/dhzdv7by5y.1
This study will be published online in iScience on November 17, 2021.
Microscopy, Electron Microscopy, Enzyme-Linked Immunosorbent Assay, Fluorescence Activated Cell Sorting, Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis